Search details
1.
Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial.
Diabetes Obes Metab
; 26(7): 2830-2838, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38602409
2.
Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trial.
Diabetes Obes Metab
; 26(7): 2774-2786, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38618970
3.
Efficacy and safety of basal-first titration order in individuals with type 2 diabetes receiving short-term intensive insulin therapy: An exploratory analysis of BEYOND V.
Diabetes Obes Metab
; 25(5): 1221-1228, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36594649
4.
Efficacy and safety of a basal insulin + 2-3 oral antihyperglycaemic drugs regimen versus a twice-daily premixed insulin + metformin regimen after short-term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open-label, randomized controlled BEYOND-V trial.
Diabetes Obes Metab
; 24(10): 1957-1966, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35642463
5.
Association between polymorphisms of cytokine genes and diabetic nephropathy: A comprehensive systematic review and meta-analysis.
Int J Clin Pract
; 75(11): e14634, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34309136
Results
1 -
5
de 5
1
Next >
>>